Andrea, et al., "Applications of Neural Networks in Quantitative Structure-Activity Relationship of Dihydrofolate Reductase Inhibitors," Journal of Medicinal Chemistry, vol. 34, No. 9, 1991, pp. 2824-2836. |
Aoyama, et al., "Neural Networks Applied to Quantitative Structure Activity Relationship Analysis," Journal of Medicinal Chemistry, 1990, vol. 33, No. 9, pp. 2583-2590. |
Aoyama, et al., "Obtaining the Correlation Indices Between Drug Activity and Structural Parameters Using a Neural Network," Chemical Pharmaceutical Bulletin, vol. 39, No. 2, 1991, pp. 372-378. |
Blankley, "Introduction: A Review of QSAR Methodology," Academic Press, Inc. (1983), pp. 1-17. |
Boulu, et al., "Voronoi Binding Site Model of a Polycyclic Aromatic Hydrocarbon Binding Protein," J. Med. Chem. (1990) vol. 33, pp. 771-775. |
Boulu, et al., "Voronoi Binding Site Models: Calculation of Binding Modes and Influence of Drug Binding Data Accuracy," Journal Of Computational Chemistry (1989) vol. 10, No. 5, pp. 673-682. |
Cramer III, et al., "Comparative Molecular Field Analysis (COMFA)," J. Am. Chem. Soc., vol. 110, No. 18 (1988) pp. 5959-5967. |
Crippen, "Voronoi Binding Site Models," Journal of Computational Chemistry (1987) vol. 8, No. 7, pp. 943-955. |
Crippen, "Deduction of Binding Site Structure From Ligand Binding Data," Annals of the New York Academy of Sciences (1984) vol. 439, pp. 1-11. |
Crippen, et al., "Distance Geometry and Molecular Confirmation," Research Studies Press Ltd., 8. Ligand Binding, pp. 361-429, No date. |
Doweyko, "The Hypothetical Active Site Lattice: An Approach To Modelling Active Sites from Data on Inhibitor Molecules," Journal of American Chemistry (1988) vol. 31, No. 7, pp. 1396-1406. |
Ghose, et al., "Use of Physicochemical Parameters in Distance Geometry and Related Three-Dimensional Quantitative Structure-Activity Relationships: A Demonstration Using Escherichia coli Dihydrofolate Reductase Inhibitors," Journal of Medicinal Chemistry, vol. 28, No. 3, 1985, pp. 333-346. |
Good, et al., "Structure-Activity Relationships from Molecular Similarity Matrices," Journal of Medicinal Chemistry, vol. 36, No. 4, Feb. 19, 1993, pp. 433-438. |
Hopfinger, "A QSAR Investigation of Dihydrofolate Reductase Inhibitors by Baker Triazines Based Upon Molecular Shape Analysis," J. Am. Chem. Soc. (1980) vol. 102, pp. 7196-7206. |
Nicklaus, et al., "QSAR of Conformationally Flexible Molecules: Comparative Molecular Field Analysis of Protein-Tyrosine Kinase Inhibitors," Journal of Computer-Aided Molecular Design (1992) vol. 6, pp. 487-504. |
Oinuma, et al., "Neural Networks Applied to Structure-Activity Relationships," Journal of Medicinal Chemistry, vol. 33, No. 3, 1990, pp. 905-908. |
Simon, et al., "Mapping of Dihydrofolate-Reductase Receiptor Site by Correlation with Minimal Topological (Steric) Differences," J. Theor. Biol. (1977), vol. 66, pp. 485-495. |
Smellie, et al., "Fast Drug-Receptor Mapping by Site-Directed Distances: A Novel Method of Predicting New Pharmacological Leads," J. Chem. Inf. Comput. Sci., vol. 31, No. 3 (1991) p. 386-392. |
Viswanadhan, et al., "Mapping the Binding Site of the Nucleoside Transporter Protein: A 3D-QSAR Study," Biochemica et Biophysica Acta., 1039 (1990) pp. 356-366. |